Seong, J., Yee, J., & Gwak, H. S. (2019). Dipeptidyl peptidase‐4 inhibitors lower the risk of autoimmune disease in patients with type 2 diabetes mellitus: A nationwide population‐based cohort study. Br J Clin Pharmacol.
استشهاد بنمط شيكاغوSeong, Jong‐Mi, Jeong Yee, و Hye Sun Gwak. "Dipeptidyl Peptidase‐4 Inhibitors Lower the Risk of Autoimmune Disease in Patients With Type 2 Diabetes Mellitus: A Nationwide Population‐based Cohort Study." Br J Clin Pharmacol 2019.
MLA استشهادSeong, Jong‐Mi, Jeong Yee, و Hye Sun Gwak. "Dipeptidyl Peptidase‐4 Inhibitors Lower the Risk of Autoimmune Disease in Patients With Type 2 Diabetes Mellitus: A Nationwide Population‐based Cohort Study." Br J Clin Pharmacol 2019.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.